相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Microsomal triglyceride transfer protein inhibitor lomitapide-induced liver toxicity is ameliorated by Triiodothyronine treatment following improved bile homeostasis and β-oxidation
Vishal Patel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2022)
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia
Arturo Cesaro et al.
HEART FAILURE CLINICS (2022)
Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation
Priya Pathak et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches
Diana Jhoseline Medina-Leyte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
Claudia Stefanutti
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia
Noriko Kameyama et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
Ana Paula M. Chacra et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes
Hatem Maamoun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation
Isabella Viana Gomes Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Endoplasmic reticulum stress and mitochondrial biogenesis are potential therapeutic targets for abdominal aortic aneurysm
Masashi Miyao et al.
CLINICAL SCIENCE (2019)
Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice
Philipp Lang et al.
SCIENTIFIC REPORTS (2019)
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
Andrew Elagizi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Endothelial Transcytosis of Lipoproteins in Atherosclerosis
Xinbo Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
MicroRNA-204 promotes vascular endoplasmic reticulum stress and endothelial dysfunction by targeting Sirtuin1
Modar Kassan et al.
SCIENTIFIC REPORTS (2017)
Role of free fatty acids in endothelial dysfunction
Arijit Ghosh et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Efficacy and Safety of Lomitapide in Hypercholesterolemia
Xin Liu et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Lomitapide
Sebastiaan C. Goulooze et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice
Ana Maria Gamez-Mendez et al.
PLOS ONE (2015)
Lipid-lowering treatment for homozygous familial hypercholesterolaemia reply
Marina Cuchel et al.
LANCET (2013)
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Marina Cuchel et al.
LANCET (2013)
Caloric Restriction Chronically Impairs Metabolic Programming in Mice
Henriette Kirchner et al.
DIABETES (2012)
Pharmacological strategies for lowering LDL cholesterol: statins and beyond
Ariel Brautbar et al.
NATURE REVIEWS CARDIOLOGY (2011)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Abstract: 103 EFFECTS OF LOW DOSE MTP INHIBITION ALONE AND IN COMBINATION WITH OTHER LIPID-LOWERING DRUGS ON HEPATIC FAT AND PLASMA LIPIDS
E Meagher et al.
ATHEROSCLEROSIS SUPPLEMENTS (2009)
Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease
Samir Parekh et al.
GASTROENTEROLOGY (2007)
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease
RC Austin et al.
CELL DEATH AND DIFFERENTIATION (2004)
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis
MJ Chen et al.
PHARMACOLOGY & THERAPEUTICS (2002)
A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors
JA Robl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Endothelial dysfunction in men with small LDL particles
J Vakkilainen et al.
CIRCULATION (2000)